Michael Jordan Levine

US Patent:

8489518, Jul 16, 2013

Filed:

Dec 16, 2009

Appl. No.:

12/639965

Inventors:

Michael B. Levine - Los Angeles CA, US
Christopher Cirak - Venice CA, US

International Classification:

G06Q 10/10
G06Q 10/06
G06Q 30/08
G06Q 10/00
G06Q 30/02

US Classification:

705321

Abstract:

A system and automated method for verification of employment history regarding a job applicant, the method including receiving information identifying an applicant, receiving employment history information for the job applicant, receiving information identifying an identified verification contact for verification of the employment history information, automatically providing the identified verification contact with a question pertaining to employment history information, receiving an answer from the identified verification contact, storing the answer.

US Patent:

20130282607, Oct 24, 2013

Filed:

Jun 14, 2013

Appl. No.:

13/918858

Inventors:

Michael B. Levine - Los Angeles CA, US
Christopher Cirak - Venice CA, US

International Classification:

G06Q 50/26

US Classification:

705321, 705325

Abstract:

A system and automated method for verification of employment history regarding a job applicant, the method including receiving information identifying an applicant, receiving employment history information for the job applicant, receiving information identifying an identified verification contact for verification of the employment history information, automatically providing the identified verification contact with a question pertaining to employment history information, receiving an answer from the identified verification contact, storing the answer.

US Patent:

44333439, Feb 21, 1984

Filed:

Dec 22, 1981

Appl. No.:

6/333465

Inventors:

Michael A. Levine - Sierra Madre CA

International Classification:

H01L 2714
H01L 2978

US Classification:

357 30

Abstract:

A relatively thin layer of extrinsic material formed on the top surface of a nearly intrinsic semiconductor substrate forms the detector area of an infrared detector device. A source region is provided along a portion of the perimeter of the detector area and is electrically coupled to the extrinsic detector area by means of an external connection. A drain channel is provided which is separated from the detector area by a gate region. The concentration of the extrinsic material in the detector area is sufficient for it to be at least a poor conductor. Thus, replacement electrons can flow from the source region into the extrinsic detector area via the external connection and electrical charge-neutrality can thereby be maintained at the extrinsic sites. The gate electrode forms a fringing field extending into the detector area which facilitates conduction from the detector area to the drain channel during the read-out process. An X-Y addressable array of such detectors can be readily fabricated using silicon MOS technology.

US Patent:

44994826, Feb 12, 1985

Filed:

Jun 25, 1982

Appl. No.:

6/392081

Inventors:

Michael A. Levine - Sierra Madre CA

International Classification:

H01L 2714

US Classification:

357 30

Abstract:

A two-gate field-effect transistor (FET) is designed to operate at cryogenic temperatures (circa 1. degree. -20. degree. K. ). For an N channel FET, the low-concentration weak-P type material used for the channel region is built into an intrinsic (or near-intrinsic) layer which in turn is built on a P type substrate. The first gate corresponds to a conventional FET control gate. The second gate may be designated a weak-source gate and is directly above a corresponding weak-source region which is itself adjacent to the conventional (strong) source region. The weak-source gate is placed at a fixed positive potential with respect to the source region so that the electrons will collect in the conduction band within the weak-source region. Once the required fixed weak-source gate potential has been established, the control gate functions in a conventional manner even when the device is at a cryogenic temperature. Such a weak-source gate over a weak-source region may be utilized to inject carriers into a charge-coupled device, or any similar device, even at cryogenic temperatures.

US Patent:

44881657, Dec 11, 1984

Filed:

Mar 15, 1982

Appl. No.:

6/357866

Inventors:

Michael A. Levine - Sierra Madre CA

International Classification:

H01L 2714
H01L 3100
H01L 2978
H01L 2912

US Classification:

357 30

Abstract:

A preferred embodiment of the invention is a three-gate charge-coupled device (CCD) which is designed to operate at cryogenic temperatures (circa 1-20. degree. K). For an N channel device, a low-concentration N type material is separated from a P type substrate by a thin layer of intrinsic material. The active detection area is underneath a transparent detector gate which functions as the device's input gate. Electrons excited into the conduction band under the detector gate flow into the conduction band under the adjoining second gate which functions as an integrating gate by collecting the electrons that flow from under the input gate. The third gate also adjoins the second gate and is called the readout gate. When the readout gate is at a low potential, it dams up the electrons in the conduction band under the integrate gate. When the readout gate is at a potential at least as high as that of the integrate gate, the electrons may flow into a drain which adjoins the readout gate provided that the drain is at a potential higher than that of the readout gate; otherwise, electrons may flow from the drain into the conduction band underneath all three gates if the drain has the lowest potential of the four.

US Patent:

20210379268, Dec 9, 2021

Filed:

Jun 4, 2021

Appl. No.:

17/339103

Inventors:

- Phoenix AZ, US
Michael Adam LEVINE - Phoenix AZ, US

Assignee:

Levine Machine, L.L.C. - Phoenix AZ

International Classification:

A61M 1/36
A61K 35/14

Abstract:

A system, device, and autologous method for treating blood. Blood is extracted from a patient. The blood is tested to determine one or more pathogens and conditions of the blood. One or more catalysts are automatically added into the blood of the patient. The one or more catalysts are activated utilizing the one or more emitters configured to interact with the one or more catalysts in the blood create treated blood. One or more additives are added into the threated blood. The treated blood is reinjected into the patient.

US Patent:

20190309783, Oct 10, 2019

Filed:

Apr 9, 2019

Appl. No.:

16/378909

Inventors:

Michael LEVINE - Phoenix AZ, US

International Classification:

F16B 25/00

Abstract:

The invention is directed to a toolless screw including a body portion which comprises a shaft portion and a screw portion which includes a shank portion and a tip portion. The shank portion includes at least two helical threads which extend off the shank either at different angles, different distances, or a combination thereof. The tip portion is positioned at an end of the shank portion and has a diameter which is less than the diameter of the shank portion and extends to a point. The body portion is integrated with a screw portion at the end of the shank portion which is opposite the end where the tip portion is positioned.